To assess whether IL-1β induces GCP-2 in SCLC cell lines, the high-GCP-2-producing H345 and H711 cells were treated by rIL-1β at a final concentration of 0.1 or 1 ng ml−1 for 24 h (Figure 3A). Here, CXCL6 is linked to small cell lung carcinoma.